ACHE and Alzheimer disease: Nowadays, as a result of very intensive and comprehensive studies related to AD, the search has expanded to developing BChE selective inhibitors, as well as AChE dual binding inhibitors, with a tendency toward these two qualities merging into the characteristics of one compound.